Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer
Daniel C. Danila, Michael J. Morris, Johann S. De Bono, Charles J. Ryan, Samuel R. Denmeade, Matthew R. Smith, Mary Ellen Taplin, Glenn J. Bubley, Thian Kheoh, Christopher Haqq, Arturo Molina, Aseem Anand, Michael Koscuiszka, Steve M. Larson, Lawrence H. Schwartz, Martin Fleisher, Howard I. Scher
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer'. Together they form a unique fingerprint.